Non-canonical Pathway for Rb Inactivation and External Signaling Coordinate Cell-cycle Entry Without CDK4/6 Activity
Overview
Authors
Affiliations
Cyclin-dependent kinases 4 and 6 (CDK4/6) are critical for initiating cell proliferation by inactivating the retinoblastoma (Rb) protein. However, mammalian cells can bypass CDK4/6 for Rb inactivation. Here we show a non-canonical pathway for Rb inactivation and its interplay with external signals. We find that the non-phosphorylated Rb protein in quiescent cells is intrinsically unstable, offering an alternative mechanism for initiating E2F activity. Nevertheless, this pathway incompletely induces Rb-protein loss, resulting in minimal E2F activity. To trigger cell proliferation, upregulation of mitogenic signaling is required for stabilizing c-Myc, thereby augmenting E2F activity. Concurrently, stress signaling promotes Cip/Kip levels, competitively regulating cell proliferation with mitogenic signaling. In cancer, driver mutations elevate c-Myc levels, facilitating adaptation to CDK4/6 inhibitors. Differentiated cells, despite Rb-protein loss, maintain quiescence through the modulation of c-Myc and Cip/Kip levels. Our findings provide mechanistic insights into an alternative model of cell-cycle entry and the maintenance of quiescence.
Lopez J, Llop-Hernandez A, Verdura S, Serrano-Hervas E, Martinez-Balibrea E, Bosch-Barrera J Cell Death Discov. 2025; 11(1):91.
PMID: 40055336 PMC: 11889205. DOI: 10.1038/s41420-025-02379-y.
Optimizing Osimertinib for NSCLC: Targeting Resistance and Exploring Combination Therapeutics.
Liao Y, Tsai C, Huang H Cancers (Basel). 2025; 17(3).
PMID: 39941826 PMC: 11815769. DOI: 10.3390/cancers17030459.
Targeting CDK4/6 in breast cancer.
Shanabag A, Armand J, Son E, Yang H Exp Mol Med. 2025; 57(2):312-322.
PMID: 39930131 PMC: 11873051. DOI: 10.1038/s12276-025-01395-3.
The interplay of p16INK4a and non-coding RNAs: bridging cellular senescence, aging, and cancer.
Balaraman A, Afzal M, Moglad E, Babu M, Priya G, Bansal P Biogerontology. 2025; 26(2):50.
PMID: 39907830 DOI: 10.1007/s10522-025-10194-2.
Armand J, Kim S, Kim K, Son E, Kim M, Yang H bioRxiv. 2024; .
PMID: 39605351 PMC: 11601343. DOI: 10.1101/2024.11.11.623139.